Related Experiment Videos
[Haemostatic defects in venous thromboembolic disease]
A Grzywacz1, P Psuja, Z Turowiecka
1Kliniki Hematologii Instytutu Chorób Wewnetrznych Akademii Medycznej.
Polskie Archiwum Medycyny Wewnetrznej
|October 1, 1995
Summary
This study screened 78 patients for clotting disorders, finding 35 with haemostatic defects. Early screening for thrombophilia is crucial for managing venous thromboembolic disease.
Area of Science:
- Hematology
- Genetics
Context:
- Venous thromboembolic disease (VTE) poses significant health risks.
- Identifying underlying haemostatic defects is key to managing VTE recurrence.
Purpose:
- To determine the prevalence of haemostatic defects in patients with a history of VTE.
- To evaluate specific clotting factors including antithrombin III, protein C, and protein S, as well as activated protein C (APC) resistance.
Summary:
- 35 out of 78 patients exhibited haemostatic defects, including low antithrombin III activity (15), reduced free protein S antigen (7), and APC resistance (5).
- Multiple defects were observed in 4 patients. Plasminogen and alfa-2-antiplasmin levels remained normal.
- Hereditary thrombophilia was identified in 6 families, underscoring the genetic component of these disorders.
Impact:
- Findings highlight the importance of comprehensive thrombophilia screening in VTE patients.
- Early detection facilitates personalized prophylaxis and treatment strategies, potentially reducing VTE events.